LRMRNasdaqPharmaceutical PreparationsFiscal year ends December 31

Larimar Therapeutics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$2.12+0.14 (+6.80%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Larimar Therapeutics, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30	Q2 2017 2017-06-30	Q1 2017 2017-03-31	Q4 2016 2016-12-31	Q3 2016 2016-09-30
Cash & Equivalents	93	178	85	90	21	21	33	35	32	110	27	39	94	112	27	86	20	63	70	72	71	62	68	101	113	39	1.01	43	37	36	49	45	41	46	41	19	32	29	32	25
Short-Term Investments	64	22	51	85	118	136	150	169	194	117	60	57	9.88	–	92	39	35	–	–	6.50	0	19	24	1.00	1.01	25	43	39	54	68	69	83	35	43	61	74	74	88	97	114
Cash & Short-Term Investments	156	200	137	175	139	158	184	204	226	239	87	96	104	112	118	125	55	63	70	78	71	81	93	102	114	64	70	82	92	105	118	128	76	89	102	93	106	117	129	139
Prepaid Expenses & Other	4.41	4.59	5.17	7.79	7.03	7.96	12	9.55	5.07	3.66	3.39	2.89	2.28	1.94	2.31	2.43	1.82	2.32	2.11	3.23	3.41	4.69	5.31	5.51	5.43	0.58	3.74	1.20	0.81	1.26	1.73	2.39	1.29	1.42	1.93	2.01	1.61	1.38	1.36	1.52
Total Current Assets	161	205	142	183	146	165	195	213	231	231	90	98	106	113	121	127	57	65	72	81	74	86	98	108	119	65	4.75	83	94	107	121	131	78	91	105	96	108	119	131	142
Property, Plant & Equipment	0.64	0.56	0.62	0.71	0.80	0.86	0.88	0.78	0.84	0.60	0.68	0.60	0.68	0.75	0.83	0.91	0.99	1.07	1.05	1.14	1.21	1.21	1.04	0.63	0.68	0.74	0.27	0.91	0.97	0.34	0.38	0.42	0.47	0.48	0.53	0.55	0.59	0.63	0.66	0.72
Gross Property, Plant & Equipment	2.66	2.52	2.52	2.52	2.52	2.49	2.42	2.25	2.24	1.91	1.91	1.75	1.75	1.75	1.75	1.75	1.75	1.75	1.65	1.65	–	1.70	1.38	0.91	0.91	–	0.45	–	–	–	0.93	–	–	–	1.04	–	–	–	0.98	–
Accumulated Depreciation	-2.02	-1.96	-1.89	-1.81	-1.72	-1.63	-1.54	-1.47	-1.39	-1.31	-1.23	-1.14	-1.07	-0.99	-0.91	-0.84	-0.76	-0.68	-0.60	-0.51	–	-0.49	-0.34	-0.28	-0.23	–	-0.18	–	–	–	-0.55	–	–	–	-0.51	–	–	–	-0.32	–
Long-Term Investments	–	–	–	–	–	–	–	–	–	12	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	3.06	1.87	2.07	2.27	2.47	2.65	2.84	3.03	3.21	2.92	3.08	2.90	2.58	2.72	2.86	3.00	3.13	3.27	3.41	3.54	3.67	3.81	3.94	4.09	4.25	6.93	0.09	7.17	7.34	0.88	–	–	–	–	–	–	–	–	–	–
Deferred Tax Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	114	–	–	–	102	–	–	–	88	–	–	–	98	–
Other Long-Term Assets	0.48	0.50	0.52	0.54	0.56	0.58	0.60	0.62	0.64	0.68	0.66	0.63	0.64	0.63	0.64	0.64	0.65	0.67	0.67	0.67	0.67	0.75	0.42	0.08	0.08	0.01	0.09	0.02	0.02	0.06	0.06	0.06	0.36	0.13	0.06	0.06	0.06	0.06	0.06	0.08
Total Assets	165	209	146	187	150	170	200	219	237	248	96	104	112	119	126	133	63	71	79	88	81	93	105	114	125	74	5.20	93	104	110	122	132	80	93	106	96	109	119	132	143
Accounts Payable	7.60	8.58	5.22	11	4.17	2.27	2.42	1.69	2.92	1.92	1.28	0.76	2.34	0.70	1.69	0.85	0.43	2.42	1.66	1.77	1.46	3.23	2.63	1.27	2.26	0.32	3.54	3.32	2.06	3.16	3.59	2.63	3.01	3.80	3.02	2.68	4.45	1.91	2.57	3.64
Accrued Expenses	25	38	58	33	21	19	21	14	17	10	7.39	5.09	4.37	6.73	8.41	7.94	6.66	5.84	6.59	7.97	5.68	4.61	5.84	3.38	3.80	0.88	2.26	1.72	3.52	–	4.26	4.90	4.45	3.66	4.27	3.09	2.71	3.85	3.73	4.58
Current Portion of Leases	1.20	1.06	1.11	1.15	1.13	1.10	1.06	1.03	0.99	0.83	0.84	0.71	0.57	0.59	0.61	0.63	0.64	0.62	0.59	0.57	0.55	0.53	0.52	0.53	0.59	0.41	0.10	0.41	0.62	0.33	–	–	–	–	–	–	–	–	–	–
Total Current Liabilities	34	48	65	45	27	22	24	16	21	13	9.51	6.56	7.28	8.01	11	9.42	7.72	8.87	8.85	10	7.69	8.38	8.99	5.18	6.65	9.87	5.90	16	13	14	13	11	9.28	7.46	7.29	7.03	9.22	8.60	9.89	11
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	6.75	8.46	10	12	14	15	17	19	20	20	–	–	–	–	1.20
Long-Term Leases	3.75	2.72	2.96	3.20	3.49	3.77	4.06	4.34	4.60	4.52	4.71	4.68	4.51	4.66	4.80	4.93	5.08	5.25	5.41	5.57	5.72	5.86	6.00	6.14	6.27	6.35	6.46	6.50	6.43	0.57	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	4.96	3.78	4.07	4.35	4.61	4.87	5.12	5.36	5.60	5.35	5.55	5.39	5.08	5.25	5.41	5.57	5.72	5.86	6.00	6.14	6.27	6.39	6.52	6.66	6.86	6.76	6.84	6.91	7.05	0.90	–	–	–	–	–	–	–	–	–	–
Total Liabilities	38	50	68	48	30	26	28	21	26	17	14	11	12	13	16	14	13	14	14	16	13	14	15	11	13	23	5.90	33	32	28	28	28	28	28	27	7.03	9.22	8.60	9.89	13
Total Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	6.75	8.46	10	12	14	15	17	19	20	20	–	–	–	–	1.20
Preferred Stock	0.00	0.00	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	–	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Common Stock	0.10	0.10	0.08	0.09	0.06	0.06	0.06	0.06	0.06	0.06	0.04	0.04	0.04	0.04	0.04	0.04	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.04	0.01	0.04	0.04	0.04	0.04	0.04	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03
Additional Paid-In Capital	625	622	513	511	444	443	441	438	436	434	270	268	266	264	262	261	184	182	181	179	158	156	155	154	154	451	22	449	448	446	444	440	373	371	368	366	364	361	359	357
Retained Earnings	-497	-464	-435	-372	-325	-298	-269	-240	-225	-203	-189	-176	-166	-158	-152	-142	-134	-125	-116	-107	-90	-78	-66	-51	-41	-400	-23	-389	-376	-364	-351	-336	-321	-306	-290	-276	-264	-251	-238	-227
Comprehensive Income & Other	-0.01	0.01	0.05	0.07	-0.01	0.05	0.15	0.36	-0.15	-0.03	0.08	0.01	0.01	–	-0.03	-0.04	-0.06	–	–	–	0.00	0.00	0.00	0.00	0.00	0.03	0.04	0.04	0.03	0.00	-0.03	-0.03	-0.01	-0.05	-0.06	-0.03	-0.04	-0.06	-0.08	-0.07
Shareholders' Equity	127	158	78	139	120	144	172	198	211	231	82	93	100	106	111	119	50	57	64	72	68	79	90	103	113	2.26	-0.69	1.90	0.54	1.22	2.91	104	52	65	78	89	100	111	122	130
Total Equity	127	158	78	139	120	144	172	198	211	231	82	93	100	106	111	119	50	57	64	72	68	79	90	103	113	2.26	-0.69	1.90	0.54	1.22	2.91	104	52	65	78	89	100	111	122	130
Total Liabilities & Equity	165	209	146	187	150	170	200	219	237	248	96	104	112	119	126	133	63	71	79	88	81	93	105	114	125	74	5.20	93	104	110	122	132	80	93	106	96	109	119	132	143
Shares Outstanding(shares)	104	104	83	86	64	64	64	64	64	64	44	44	43	43	43	43	18	18	18	18	15	15	15	15	15	37	6.09	37	37	37	37	37	28	28	27	27	27	27	27	27

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -132.6%

Financial strength

Current ratio: 4.70
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 271.3%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –